277 related articles for article (PubMed ID: 9855328)
21. Readmissions and adverse drug reactions in internal medicine: the economic impact.
Dormann H; Neubert A; Criegee-Rieck M; Egger T; Radespiel-Tröger M; Azaz-Livshits T; Levy M; Brune K; Hahn EG
J Intern Med; 2004 Jun; 255(6):653-63. PubMed ID: 15147529
[TBL] [Abstract][Full Text] [Related]
22. Adverse drug reactions related to hospital admission in Slovak elderly patients.
Wawruch M; Zikavska M; Wsolova L; Kuzelova M; Kahayova K; Strateny K; Kristova V
Arch Gerontol Geriatr; 2009; 48(2):186-90. PubMed ID: 18313773
[TBL] [Abstract][Full Text] [Related]
23. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization.
von Euler M; Eliasson E; Ohlén G; Bergman U
Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):179-84. PubMed ID: 16184621
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and characteristics of adverse drug reactions in neurosurgical intensive care patients.
Smith KM; Jeske CS; Young B; Hatton J
Neurosurgery; 2006 Mar; 58(3):426-33; discussion 426-33. PubMed ID: 16528181
[TBL] [Abstract][Full Text] [Related]
25. [Preventability of adverse effects in a medical emergency service].
Olivier P; Boulbès O; Tubery M; Carles P; Montastruc JL; Lapeyre-Mestre M
Therapie; 2001; 56(3):275-8. PubMed ID: 11482315
[TBL] [Abstract][Full Text] [Related]
26. Adverse drug reactions in an elderly outpatient population.
Schneider JK; Mion LC; Frengley JD
Am J Hosp Pharm; 1992 Jan; 49(1):90-6. PubMed ID: 1570873
[TBL] [Abstract][Full Text] [Related]
27. Drug-related hospitalizations in a tertiary care internal medicine service of a Canadian hospital: a prospective study.
Samoy LJ; Zed PJ; Wilbur K; Balen RM; Abu-Laban RB; Roberts M
Pharmacotherapy; 2006 Nov; 26(11):1578-86. PubMed ID: 17064202
[TBL] [Abstract][Full Text] [Related]
28. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals.
Bond CA; Raehl CL
Pharmacotherapy; 2006 Jun; 26(6):735-47. PubMed ID: 16716127
[TBL] [Abstract][Full Text] [Related]
29. Adverse reactions of anti-tuberculosis drugs in hospitalized patients: incidence, severity and risk factors.
Javadi MR; Shalviri G; Gholami K; Salamzadeh J; Maghooli G; Mirsaeedi SM
Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1104-10. PubMed ID: 17823987
[TBL] [Abstract][Full Text] [Related]
30. Analysis of adverse drug reactions for preventability.
Ducharme MM; Boothby LA
Int J Clin Pract; 2007 Jan; 61(1):157-61. PubMed ID: 17229189
[TBL] [Abstract][Full Text] [Related]
31. Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece.
Alexopoulou A; Dourakis SP; Mantzoukis D; Pitsariotis T; Kandyli A; Deutsch M; Archimandritis AJ
Eur J Intern Med; 2008 Nov; 19(7):505-10. PubMed ID: 19013378
[TBL] [Abstract][Full Text] [Related]
32. Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs.
Jarernsiripornkul N; Kakaew W; Loalukkana W; Krska J
Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):240-5. PubMed ID: 19148880
[TBL] [Abstract][Full Text] [Related]
33. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.
Blenkinsopp A; Wilkie P; Wang M; Routledge PA
Br J Clin Pharmacol; 2007 Feb; 63(2):148-56. PubMed ID: 17274788
[TBL] [Abstract][Full Text] [Related]
34. Evaluating the positive predictive values of antidote signals to detect potential adverse drug reactions (ADRs) in the medical intensive care unit (ICU).
Kane-Gill SL; Bellamy CJ; Verrico MM; Handler SM; Weber RJ
Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1185-91. PubMed ID: 19728294
[TBL] [Abstract][Full Text] [Related]
35. Adverse drug reactions in hospitalized children in Fortaleza, Brazil.
dos Santos DB; Coelho HL
Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):635-40. PubMed ID: 16287200
[TBL] [Abstract][Full Text] [Related]
36. Adverse drug reaction-related hospitalisations: a population-based cohort study.
van der Hooft CS; Dieleman JP; Siemes C; Aarnoudse AJ; Verhamme KM; Stricker BH; Sturkenboom MC
Pharmacoepidemiol Drug Saf; 2008 Apr; 17(4):365-71. PubMed ID: 18302300
[TBL] [Abstract][Full Text] [Related]
37. Multidisciplinary adverse drug reaction surveillance program.
Prosser TR; Kamysz PL
Am J Hosp Pharm; 1990 Jun; 47(6):1334-9. PubMed ID: 2368727
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of hospital admissions associated with digitalis glycosides].
Schmiedl S; Szymanski J; Rottenkolber M; Drewelow B; Haase G; Hippius M; Reimann IR; Siegmund W; May K; Haack S; Hasford J; Thürmann PA;
Med Klin (Munich); 2007 Aug; 102(8):603-11. PubMed ID: 17694280
[TBL] [Abstract][Full Text] [Related]
39. Use of standardized screening procedures to identify adverse drug reactions.
Koch KE
Am J Hosp Pharm; 1990 Jun; 47(6):1314-20. PubMed ID: 2368724
[TBL] [Abstract][Full Text] [Related]
40. Reporting adverse drug reactions on a geriatric ward: a pilot project.
Somers A; Petrovic M; Robays H; Bogaert M
Eur J Clin Pharmacol; 2003 Feb; 58(10):707-14. PubMed ID: 12610749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
